Author

Shubing Wang

University of California, Los AngelesPrimary ORCID profile (0009-0003-9878-7023 · 1 paper)Unclaimed ORCID profile · follow to get notified of new preprints

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Same name, identified by ORCID

Shubing WangiD1 paper · Brigham and Women's Hospital

Biology Disciplines

Click to filter author papers

Bioengineering· 1 Immunology· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Research Focus:differential expression· 2 Organism:human· 2 Assay:scRNA-seq· 2 Approach:benchmark study· 1 Research Focus:cell type annotation· 1 Research Focus:cell-cell communication· 1 Research Focus:database / resource· 1 Approach:deep learning· 1

Frequent Co-Authors

Qian Wang· 2 shared Yan-Ruide LiiD· 2 shared B Y ZhangiD· 1 shared Debiao LiiD· 1 shared Haochen NaniD· 1 shared Haoran Li· 1 shared Haoyan Ding· 1 shared Jennifer SotoiD· 1 shared

Activity by Year

2026-2026 · peak 2/yr

Co-Author Collaboration Network

10 top collaborators · 38 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

2 shared papersImmunology

Qian Wang

Mutual co-authors in cluster

Author profile →

2 papers

Recent·Most cited

C1Q-associated adaptive myeloid remodelling accompanies early response to BCMA CAR-T therapy in multiple myeloma

Shubing Wang, Qian Wang, Yan-Ruide Li, Song Li

In a ten-patient multiple myeloma reanalysis, myeloid pseudobulk from day-30 BCMA CAR-T responders showed C1Q enrichment with interferon-γ signalling, not cholesterol efflux; patient-level composite scores stayed exploratory.

bioRxiv · Aug 25, 2026 · PreprintImmunology✦ In-depth digest

BioPathfinder: Evidence-guided multi-agent platform enables hypothesis discovery for CAR-T engineering

Shubing Wang, Yan-Ruide Li, Qian Wang, Youcheng Yang, Xinyuan Shen, Haoran Li, Haochen Nan, Z J Chen, Yichen Zhu, B Y Zhang, Haoyan Ding, Jennifer Soto, Soomin Park, Yi Zheng, Xiangliang Huang, Debiao Li

A provenance-tracked multi-agent system curated 57 CAR-T patient scRNA-seq studies, generated reviewable hypotheses, and prioritized KLRC1/NKG2A, whose blockade improved CD8+ CAR-T antitumour activity in a Raji xenograft model.

bioRxiv · Jul 28, 2026 · PreprintBioengineering✦ In-depth digest